Baxter International Inc said on Tuesday that it would purchase privately held Swedish dialysis product company Gambro AB for about $4 billion to complement its kidney therapy portfolio.Baxter will finance the deal, which it expects to close in the first half of 2013, with debt and cash generated from overseas operations.The company, which posted sales of $13.89 billion in 2011, manufactures kidney dialysis equipment, drug infusion pumps and blood therapy products. The Gambro acquisition will round out Baxter's renal business, which accounts for almost one-fifth of the company's revenue.Gambro is one of the largest makers of equipment for hemodialysis, which is generally performed in a hospital or clinic. The dialysis from Baxter's machines is called peritoneal and can be performed at home.
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Shares of BAX remained unchanged at $65.80. In the past year, the shares have traded as low as $47.55 and as high as $68.91. On average, 3111020 shares of BAX exchange hands on a given day and today's volume is recorded at 0.
Source
